News
Access to care discussed in key issues dialogue
KING OF PRUSSIA, PA – CSL Behring has just published “Access to Care,” which addresses many of the practices that impede access to care for people with rare and serious medical disorders, and possible solutions. This discussion is especially relevant now as healthcare reform is being implemented to assure that people with rare diseases do not end up with reduced care as an unintended consequence.
This is the latest in the company’s “Key Issues Dialogues,” an ongoing series that analyzes critical issues of importance to patients who use human plasma-derived and recombinant coagulation factor therapies and to caregivers and healthcare providers.
John Walsh
Among those taking part in the dialogue is John Walsh, Alpha-1 Foundation president & CEO.
The participants in the dialogue have a frank exchange about current access to care issues that make it difficult for some people with serious and rare medical conditions to obtain life-saving therapies. They address a wide range of important issues including evidence-based medicine, cost versus coverage decisions, step therapy, defensive medicine and tort reform, consumers’ responsibility to question necessity and cost, and the vulnerability of people with rare diseases to cost shifting through co-pays.
